Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2015 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
JOUNCE THERAPEUTICS, INC. | 20 | Q3 2022 | 100.0% |
ALLENA PHARMACEUTICALS, INC. | 19 | Q2 2022 | 24.4% |
BLUEPRINT MEDICINES CORPORATION | 6 | Q1 2019 | 47.1% |
REVOLUTION MEDICINES, INC. | 5 | Q1 2021 | 55.4% |
SAGE THERAPEUTICS, INC. | 5 | Q4 2018 | 16.3% |
MYOKARDIA, INC. | 2 | Q1 2018 | 21.9% |
View TRV GP II, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2022-11-03 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-10 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-05 |
4 | 2021-09-17 |
13F-HR | 2021-08-11 |
4 | 2021-06-14 |
4 | 2021-06-07 |
4 | 2021-05-27 |
View TRV GP II, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.